|
Systematic assessment of LCMV based vaccine vectors expressing melanocyte differentiation antigens in human in vitro assays and in mouse melanoma models. |
|
|
Stock and Other Ownership Interests - Hookipa Pharma |
Research Funding - Hookipa Pharma |
Patents, Royalties, Other Intellectual Property - Hookipa Pharma |
Travel, Accommodations, Expenses - Hookipa Pharma |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Hookipa Biotech (I) |
Leadership - Hookipa Biotech (I) |
Stock and Other Ownership Interests - Hookipa Biotech (I) |
Honoraria - Hookipa Biotech (I) |
Research Funding - Hookipa Biotech (I) |
Patents, Royalties, Other Intellectual Property - Hookipa Biotech |
Travel, Accommodations, Expenses - Hookipa Biotech (I) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Hookipa Biotech |
|
|
Employment - Hookipa Biotech |
Stock and Other Ownership Interests - Hookipa Biotech |
Research Funding - Hookipa Biotech |
Patents, Royalties, Other Intellectual Property - Hookipa Biotech |
Travel, Accommodations, Expenses - Hookipa Biotech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Research Funding - Hookipa Pharma (Inst) |
Patents, Royalties, Other Intellectual Property - Hookipa Pharma |